XFXueqi Fu

Xueqi Fu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xueqi Fu has a total of 302 co-authors. Here are the top co-authors by number of shared publications:

  • Shu Xing

    Key Laboratory for Molecular Enzymology and Engineering of Ministry of Education, School of Life Sciences, Jilin University, Qianjin road 2699, Changchun 130012, China

    20 shared publications
  • Miaoli Zhu

    Institute of Molecular Science, Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Shanxi University, 92 Wucheng Road, Taiyuan, Shanxi 030006, People's Republic of China

    11 shared publications
  • Liping Lu

    Institute of Molecular Science, Key Laboratory of Chemical Biology and Molecular Engineering of the Education Ministry, Shanxi University, Taiyuan, Shanxi 030006, People's Republic of China

    10 shared publications
  • Zhizhuang Joe Zhao

    Department of Pathology, University of Oklahoma Health Sciences Center, 940 Stanton L. Young Blvd., BMSB 451, Oklahoma City, OK 73104, USA

    10 shared publications
  • Junfeng Ma

    National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun 130012, China

    9 shared publications
  • Bo Cao

    Department of Endocrinology & Metabolism, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    6 shared publications

Latest Publications

  • Open Access

    Cytotoxic Effect of a β1,4-Galactosyltransferase Inhibitor in Hepatic Carcinoma Cells

    by Zhe Dai, Ming Sun, Lihang Chen, Xueqi Fu, Wenfu Yan, Yin Gao, Inka Brockhausen

    The incidence and mortality of hepatocellular carcinoma (HCC) are increasing worldwide, underscoring the need for novel therapeutic strategies. Synthetic 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-d-glucopyranoside (612) is a selective inhibitor of β1,4-galactosyltransferase 1 (β4GalT1). In this study, we investigated the cytotoxic effects of 612 across multiple cancer cell lines, with a focus on HCC, and explored the underlying mechanisms. We demonstrate that 612 preferentially exhibits cytotoxicity toward cancer cells with elevated expression of β4GalT family members, while human umbilical vein endothelial cells and immortalized human embryonic kidney epithelial cells are comparatively less sensitive. Treatment with 612 suppresses cancer cell migration and invasion and induces pronounced endoplasmic reticulum and Golgi stress, accompanied by G2/M cell cycle arrest. Furthermore, 612 activates apoptosis through ER stress–associated pathways by downregulating the anti-apoptotic protein Bcl-2 and upregulating pro-apoptotic proteins Bax and Bak, along with activation of caspase-3, -8, and -9. Collectively, these findings identify 612 as a promising anti-cancer candidate targeting β4GalTs-overexpressing HCC cells and warrant further therapeutic development.

  • Open Access

    Molecular Engineering of Recombinant Protein Hydrogels: Programmable Design and Biomedical Applications

    by He Zhang, Jiangning Wang, Jiaona Wei, Xueqi Fu, Junfeng Ma, Jing Chen

    Recombinant protein hydrogels have emerged as transformative biomaterials that overcome the bioinertness and unpredictable degradation of traditional synthetic systems by leveraging genetically engineered backbones, such as elastin-like polypeptides, SF, and resilin-like polypeptides, to replicate extracellular matrix (ECM) dynamics and enable programmable functionality. Constructed through a hierarchical crosslinking strategy, these hydrogels integrate reversible physical interactions with covalent crosslinking approaches, collectively endowing the system with mechanical strength, environmental responsiveness, and controlled degradation behavior. Critically, molecular engineering strategies serve as the cornerstone for functional precision: domain-directed self-assembly exploits coiled-coil or β-sheet motifs to orchestrate hierarchical organization, while modular fusion of bioactive motifs through genetic encoding or site-specific conjugation enables dynamic control over cellular interactions and therapeutic release. Such engineered designs underpin advanced applications, including immunomodulatory scaffolds for diabetic wound regeneration, tumor-microenvironment-responsive drug depots, and shear-thinning bioinks for vascularized bioprinting, by synergizing material properties with biological cues. By uniting synthetic biology with materials science, recombinant hydrogels deliver unprecedented flexibility in tuning physical and biological properties. This review synthesizes emerging crosslinking paradigms and molecular strategies, offering a framework for engineering next-generation, adaptive biomaterials poised to address complex challenges in regenerative medicine and beyond.


  • Open Access

    Unlocking the Potential of Curcumae Rhizoma Aqueous Extract in Stress Resistance and Extending Lifespan in Caenorhabditis elegans

    by Linyao Jing, Yanlin Zhao, Lijun Jiang, Fei Song, Lu An, Edmund Qi, Xueqi Fu, Jing Chen, Junfeng Ma

    The enhancement of stress resistance is crucial for delaying aging and extending a healthy lifespan. Traditional Chinese medicine (TCM), a cherished treasure of Chinese heritage, has shown potential in mitigating stress and promoting longevity. This study integrates network pharmacology and in vivo analysis to investigate the mechanisms and effects of Curcumae Rhizoma (C. Rhizoma), known as “E Zhu” in Chinese. Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry (UPLC-MS/MS) identified 10 active compounds in its aqueous extract, interacting with 128 stress-related targets. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses revealed pathways such as stress response, FoxO signaling, and insulin resistance. In Caenorhabditis elegans, 10 mg/mL of C. Rhizoma aqueous extract improved resistance to UV, thermal, oxidative, and pathogen-induced stress, extending lifespan in a dose-dependent manner. Mechanistically, it reduced reactive oxygen species (ROS), increased superoxide dismutase (SOD) activity, and enhanced UV resistance via the insulin/IGF-1 pathway and DAF-16 translocation. Molecular docking highlighted hexahydrocurcumin (HHC) and related compounds as key bioactives. Furthermore, we also observed that C. Rhizoma aqueous extract significantly extended both the lifespan and healthspan of nematodes. These findings highlight the potential of C. Rhizoma in stress mitigation and longevity promotion, offering valuable insights into the therapeutic applications of TCM.


  • Open Access

    Computational insights into exploring the potential effects of environmental contaminants on human health

    by Fuyan Cao, Xinyue Zhao, Xueqi Fu, Yue Jin

    The rise in human activity has intensified environmental pollution, posing a global public health challenge. Understanding the intricate mechanisms by which pollutants impact health is crucial. Traditional research, often limited to specific techniques and short-term exposures, fails to capture the full complexity of these interactions. This study integrates machine-learning, quantum chemical computing, physicochemical properties, target prediction, KEGG and GO pathway analyses and survival analysis to examine the effects of air and water pollutants on human health. We chose knowledge-guided pre-trained graph transformer (KPGT) framework with an AUC of 0.83 knowledge bootstrap to predict the carcinogenic potential of pollutants and clustered environmental pollutants into seven different groups. For each group, quantum chemical and physicochemical properties, target prediction, KEGG and GO pathway analyses further revealed links between pollutants and cancer-related factors, such as MicroRNA, PD-L1, the PD-1 checkpoint pathway, and HIF-1 signaling. Survival analysis identified key proteins associated with poor cancer prognosis. These findings provide insights into the complex effects of pollutants on health and contribute to public health research.

  • Open Access

    Investigating the Vital Role of the Identified Abietic Acid from Helianthus annuus L. Calathide Extract against Hyperuricemia via Human Embryonic Kidney 293T Cell Model

    by Huining Dai, Xiao Xu, Wannan Li, Xueqi Fu, Weiwei Han, Guodong Li

    To explore the anti-hyperuricemia components in sunflower (Helianthus annuus L.) calathide extract (SCE), we identified abietic acid (AA) via liquid chromatography–mass spectrometry and found an excellent inhibitor of xanthine oxidase (IC50 = 10.60 µM, Ki = 193.65 nM) without cytotoxicity. Based on the transcriptomics analysis of the human embryonic kidney 293T cell model established using 1 mM uric acid, we evaluated that AA showed opposite modulation of purine metabolism to the UA group and markedly suppressed the intensity of purine nucleoside phosphorylase, ribose phosphate pyrophosphokinase 2, and ribose 5-phosphate isomerase A. Molecular docking also reveals the inhibition of purine nucleoside phosphorylase and ribose phosphate pyrophosphokinase 1. The SCE exhibits similar regulation of these genes, so we conclude that AA was a promising component in SCE against hyperuricemia. This present study provided a novel cell model for screening anti-hyperuricemia natural drugs in vitro and illustrated that AA, a natural diterpenoid, is a potential inhibitor of purine biosynthesis or metabolism.


  • Open Access

    Supplementary Figure 6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

    by Jing Li, Bo Cao, Xichun Liu, Xueqi Fu, Zhenggang Xiong, Li Chen, Oliver Sartor, Yan Dong, Haitao Zhang

    Supplementary Figure 6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

  • Open Access

    Supplementary Figure 1 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

    by Jing Li, Bo Cao, Xichun Liu, Xueqi Fu, Zhenggang Xiong, Li Chen, Oliver Sartor, Yan Dong, Haitao Zhang

    Supplementary Figure 1 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

  • Open Access

    Supplementary Figure 3 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

    by Jing Li, Bo Cao, Xichun Liu, Xueqi Fu, Zhenggang Xiong, Li Chen, Oliver Sartor, Yan Dong, Haitao Zhang

    Supplementary Figure 3 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

  • Open Access

    Supplementary Figure Legends 1-6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

    by Jing Li, Bo Cao, Xichun Liu, Xueqi Fu, Zhenggang Xiong, Li Chen, Oliver Sartor, Yan Dong, Haitao Zhang

    Supplementary Figure Legends 1-6 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

  • Open Access

    Supplementary Figure 5 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer

    by Jing Li, Bo Cao, Xichun Liu, Xueqi Fu, Zhenggang Xiong, Li Chen, Oliver Sartor, Yan Dong, Haitao Zhang

    Supplementary Figure 5 from Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer